Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains

FEBS Letters

Volumn 583, Issue 13, 2009, Pages 2194-2200

  Sasaki, Kumi ^a,b   Shimura, Hideki ^a,b   Itaya, Masako ^c   Tanaka, Ryota ^a   Mori, Hideo ^d   Mizuno, Yoshikuni ^d   Kosik, Kenneth S ^e   Tanaka, Shigeki ^a   Hattori, Nobutaka ^c  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b Institute for Environment and Gender Specific Medicine   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Juntendo University Hospital   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Corticobasal degeneration; EAAT2; Neurofibrillary tangle; Progressive supranuclear palsy; Tau

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; NEUROTRANSMITTER UPTAKE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TAUOPATHY;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BRAIN; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUROFIBRILLARY TANGLES; TAU PROTEINS; TAUOPATHIES;

EID: 67649336238     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.06.015     Document Type: Article

References (24)

1. Buée L., Bussière T., Buée-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33 (2000) 95-130
2. Hutton M. Molecular genetics of chromosome 17 tauopathies. Ann. NY Acad. Sci. 920 (2000) 63-73
3. Trojanowski J.Q., and Lee V.M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 9 (1995) 1570-1576
4. Kosik K.S. Tau protein and neurodegeneration. Mol. Neurobiol. 4 (1990) 171-179
5. Geschwind D.H. Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg?. Neuron 40 (2003) 457-460
6. Noble W., et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (2003) 555-565
7. Jackson G.R., Wiedau-Pazos M., Sang T.K., Wagle N., Brown C.A., Massachi S., and Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34 (2002) 509-519
8. Shimura H., Schwartz D., Gygi S.P., and Kosik K.S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279 (2004) 4869-4876
9. Shimura H., Miura-Shimura Y., and Kosik K.S. Binding of tau to heat shock protein 27 leads to decreased concentration of phosphorylated tau and enhanced cell survival. J. Biol. Chem. 279 (2004) 17957-17962
10. Rothstein J.D., Jin L., Dykes-Hoberg M., and Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90 (1993) 6591-6595
11. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., and Selkoe D.J. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293 (2001) 263-269
12. Greenberg S.G., Davies P., Schein J.D., and Binder L.I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267 (1992) 564-569
13. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., and Mizuno Y. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45 (1999) 668-672
14. Wang Q., Woltjer R.L., Cimino P.J., Pan C., Montine K.S., Zhang J., and Montine T.J. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 19 (2005) 869-871
15. Goldberg M.S., and Lansbury Jr. P.T. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?. Nat. Cell Biol. 2 (2000) E115-E119
16. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
17. Scott H.L., Tannenberg A.E.G., and Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer disease cerebral cortex. J. Neurochem. 64 (1995) 2193-2202
18. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 33 (1999) 479-491
19. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., and Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14 (1994) 5559-5569
20. Dong X.X., Wang Y., and Qin Z.H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 30 (2009) 379-387
21. Tanaka K., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-1702
22. Masliah E., et al. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40 (1996) 759-766
23. Scott H.L., Pow D.V., Tannenberg A.E., and Dodd P.R. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J. Neurosci. 22 (2002) RC206
24. Thai D.R. Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease. Brain Pathol. 12 (2002) 405-411